Stay updated with breaking news from Therapy Acceleration Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LLS TAP is a strategic funding initiative to accelerate innovative blood cancer therapeutics Strategic equity investment of €3 million to support clinical advancement of EO2463 in Non-Hodgkin's Lymphoma PARIS, Oct.
Now there are encouraging signs that CLL could join the list of blood cancers that can be effectively treated with CAR T-cell therapy.
LUND, SE / ACCESSWIRE / April 26, 2023 / BioInvent International (STO:BINV)"After the end of the quarter, we received very positive news in our BI-1206 project. We now have a fourth complete response in
LUND, SE / ACCESSWIRE / January 31, 2023 / BioInvent International (STO:BINV)Lund, Sweden, January 31, 2023 - BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV) today announced that the